<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>At the Children's Hospital, University of Helsinki, Finland, bone marrow transplantations have been performed since 1974 </plain></SENT>
<SENT sid="1" pm="."><plain>Between 1974 and 1992, 62 children received allogeneic bone marrow grafts </plain></SENT>
<SENT sid="2" pm="."><plain>Median patient age was 9.3 years </plain></SENT>
<SENT sid="3" pm="."><plain>Thirty-two patients had ALL, 13 AML and 11 had severe <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> (SAA) </plain></SENT>
<SENT sid="4" pm="."><plain>Graft failure occurred in 4 of the 62 patients </plain></SENT>
<SENT sid="5" pm="."><plain>The overall long-term survival rate was 47% </plain></SENT>
<SENT sid="6" pm="."><plain>Relapse of <z:hpo ids='HP_0001909'>leukemia</z:hpo> was the most common cause of <z:hpo ids='HP_0011420'>death</z:hpo>, especially in patients with ALL transplanted in second or later remission </plain></SENT>
<SENT sid="7" pm="."><plain><z:hpo ids='HP_0011420'>Deaths</z:hpo> during the first 2 months after transplant have decreased with time </plain></SENT>
<SENT sid="8" pm="."><plain>In a small country such as Finland, it is important to centralize the experience of allogeneic BMTs, particularly for pediatric patients </plain></SENT>
</text></document>